Irish Startup Reformulates Generic Endometriosis Drug Without Animal-Derived Ingredients
Save
Non-Food

Irish Startup Reformulates Generic Endometriosis Drug Without Animal-Derived Ingredients

Vegconomist • Nov 17, 2026
Dublin-based Zero Animal Biotech has partnered with Indian manufacturer Akums Drugs & Pharmaceuticals to reformulate the endometriosis drug dienogest to eliminate animal-derived ingredients like lactose and gelatin. This innovative approach addresses the needs of patients who are lactose intolerant, vegan, or have dietary restrictions due to religious beliefs. Zero Animal Biotech aims to maintain the active ingredient while transitioning to plant-based alternatives for the excipients. The company, which was founded in 2026, is focused on developing vegan formulations of existing generic medications, with dienogest being its first project.

Founder Sarit Hashkes, who is both vegan and lives with endometriosis, is personally invested in this initiative. She has documented her journey in a video series titled "Can I Stop Being a Hypocrite?" on social media. Hashkes emphasizes the pressing need for vegan options in the pharmaceutical market, as many commonly prescribed medicines contain animal-derived ingredients. Zero Animal Biotech's efforts not only aim to address ethical concerns but also tap into a market worth over $2 billion, thereby catering to a growing demand for vegan health solutions.
*This summary was generated using AI.
Read Full Article

Related recipes, books, documentaries, and topics from our catalog.

Community reviews

Sign in to leave the first review.

Discussion Join the conversation

Sign in to start the discussion.